Your browser doesn't support javascript.
loading
Plasma AR status and cabazitaxel in heavily treated metastatic castration-resistant prostate cancer.
Conteduca, Vincenza; Castro, Elena; Wetterskog, Daniel; Scarpi, Emanuela; Jayaram, Anuradha; Romero-Laorden, Nuria; Olmos, David; Gurioli, Giorgia; Lolli, Cristian; Sáez, Maria Isabel; Puente, Javier; Schepisi, Giuseppe; Salvi, Samanta; Wingate, Anna; Medina, Ana; Querol-Niñerola, Rosa; Marin-Aguilera, Mercedes; Arranz, Jose Angel; Fornarini, Giuseppe; Basso, Umberto; Mellado, Begoña; Gonzalez-Billalabeitia, Enrique; Attard, Gerhardt; De Giorgi, Ugo.
Afiliação
  • Conteduca V; Istituto Scientifico Romagnolo per Io Studio e La Cura dei Tumori (IRST) IRCCS, Meldola, Italy; University College London Cancer Institute, London, UK. Electronic address: vincenza.conteduca@irst.emr.it.
  • Castro E; Prostate Cancer Research Unit, Spanish National Cancer Research Centre (CNIO), Madrid, Spain; Hospital Universitario Quirón, Madrid, Spain.
  • Wetterskog D; University College London Cancer Institute, London, UK.
  • Scarpi E; Istituto Scientifico Romagnolo per Io Studio e La Cura dei Tumori (IRST) IRCCS, Meldola, Italy.
  • Jayaram A; University College London Cancer Institute, London, UK.
  • Romero-Laorden N; Prostate Cancer Research Unit, Spanish National Cancer Research Centre (CNIO), Madrid, Spain; Medical Oncology Department, Hospital Universitario La Princesa, Madrid, Spain.
  • Olmos D; Prostate Cancer Research Unit, Spanish National Cancer Research Centre (CNIO), Madrid, Spain; CNIO-IBIMA Genitourinary Cancer Unit, Hospitales Universitarios Virgen de Ia Victoria y Regional de Málaga, Instituto de Investigación Biomédica de Málaga, Spain.
  • Gurioli G; Istituto Scientifico Romagnolo per Io Studio e La Cura dei Tumori (IRST) IRCCS, Meldola, Italy.
  • Lolli C; Istituto Scientifico Romagnolo per Io Studio e La Cura dei Tumori (IRST) IRCCS, Meldola, Italy.
  • Sáez MI; CNIO-IBIMA Genitourinary Cancer Unit, Hospitales Universitarios Virgen de Ia Victoria y Regional de Málaga, Instituto de Investigación Biomédica de Málaga, Spain.
  • Puente J; Medical Oncology Department, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), CIBERONC, Madrid, Spain.
  • Schepisi G; Istituto Scientifico Romagnolo per Io Studio e La Cura dei Tumori (IRST) IRCCS, Meldola, Italy.
  • Salvi S; Istituto Scientifico Romagnolo per Io Studio e La Cura dei Tumori (IRST) IRCCS, Meldola, Italy.
  • Wingate A; University College London Cancer Institute, London, UK.
  • Medina A; Medical Oncology Department, Centro Oncológico de Galicia, A Coruña, Spain.
  • Querol-Niñerola R; Hospital de Mataró, Mataró, Spain.
  • Marin-Aguilera M; Medical Oncology Department, IDIBAPS, Hospital Clínico y Provincial, Barcelona, Spain.
  • Arranz JA; Medical Oncology Department, Gregorio Marañón University Hospital, Madrid, Spain.
  • Fornarini G; Medical Oncology Unit, Ospedale Policlinico San Martino, Genoa, Italy.
  • Basso U; Medical Oncology Unit 1, Istituto Oncologico Veneto IOV IRCCS, Padua, Italy.
  • Mellado B; Medical Oncology Department, IDIBAPS, Hospital Clínico y Provincial, Barcelona, Spain.
  • Gonzalez-Billalabeitia E; Department of Hematology & Medical Oncology, Hospital Universitario Morales Meseguer, IMIB-Universidad de Murcia, Murcia, Spain; Universidad Católica San Antonio de Murcia-UCAM, Murcia, Spain.
  • Attard G; University College London Cancer Institute, London, UK. Electronic address: g.attard@ucl.ac.uk.
  • De Giorgi U; Istituto Scientifico Romagnolo per Io Studio e La Cura dei Tumori (IRST) IRCCS, Meldola, Italy.
Eur J Cancer ; 116: 158-168, 2019 07.
Article em En | MEDLINE | ID: mdl-31200322
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Adenocarcinoma / Receptores Androgênicos / Biomarcadores Tumorais / Taxoides / Neoplasias de Próstata Resistentes à Castração / Antineoplásicos Tipo de estudo: Clinical_trials / Guideline / Prognostic_studies Limite: Adult / Aged / Aged80 / Humans / Male / Middle aged Idioma: En Revista: Eur J Cancer Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Adenocarcinoma / Receptores Androgênicos / Biomarcadores Tumorais / Taxoides / Neoplasias de Próstata Resistentes à Castração / Antineoplásicos Tipo de estudo: Clinical_trials / Guideline / Prognostic_studies Limite: Adult / Aged / Aged80 / Humans / Male / Middle aged Idioma: En Revista: Eur J Cancer Ano de publicação: 2019 Tipo de documento: Article